Quality isn’t just a checklist; it’s a culture sustained by expertise.

While our equipment is state-of-the-art, our true strength lies in our Quality Leadership Team. Our facility is managed by over 50+ QA/QC specialists, including seasoned toxicologists, analytical chemists, and regulatory compliance experts.

• Deep Expertise: Our senior auditors bring an average of 12+ years of experience from the pharmaceutical and nutraceutical industries.

• Continuous Training: Every operator undergoes bi-annual cGMP competency certification to ensure that “Quality by Design” is implemented at every workstation, not just in the lab.

• Uncompromising Culture: Our QC team holds “Stop-Line Authority”—empowering any specialist to halt production if a single deviation is suspected.

We don’t claim quality — we quantify it.

• ISO Class 8 (Class 100,000) cleanrooms with continuous environmental monitoring
• Differential pressure: ±10 Pa | Temperature: ±1°C
• 400+ pesticide residues screened (vs. ~200 industry norm)
• Full batch documentation: COA + BPR + retained samples

✔ Internal heavy metal limits are set significantly below pharmacopeial thresholds, with up to 20× tighter control depending on raw material risk profile.

• For Botanical Extracts (The Traceability Engine):

  We solve the “Natural Variability” challenge through total transparency. From our GAP-aligned cultivation bases to the final extract, every batch is tied to a Geographic Origin Certificate. We utilize HPTLC fingerprinting to ensure you receive the full phytochemical profile intended by nature, with zero adulteration.

• For Synthetic Nutrients (The Purity Precision):

  For high-purity compounds, we focus on the molecular level. Our focus shifts to Impurity Profiling and Residual Solvent Control (USP <467>). Using HPLC and LC-MS/MS, we guarantee assay consistency within  ±2% of specifications, ensuring your formula remains stable and potent.

Process Deviation Control

• Critical Process Parameter (CPP) Monitoring
  Real-time digital tracking of extraction temperature, pressure, and duration

• Blending & Granulation Uniformity
  High-shear granulation systems validated to achieve: Relative Standard Deviation (RSD) < 5% for active ingredient distribution

• Cross-Contamination Prevention
  • Campaign-based production scheduling
  • Automated CIP (Clean-in-Place) systems
  • Cleaning validation via swab sampling + HPLC analysis
  • Residue control based on MACO (Maximum Allowable Carryover) calculations
• Deviation Handling System
  Automatic batch hold triggered by OOS/OOT events, followed by 24-hour CAPA initiation

We conduct both real-time and accelerated stability studies in fully validated, ICH-compliant environmental chambers with continuous monitoring and data logging.

• Long-Term Conditions: 25°C ± 2°C / 60% RH ± 5%
• Accelerated Conditions: 40°C ± 2°C / 75% RH ± 5%

All studies are designed and executed in accordance with ICH Q1A (R2) guidelines, ensuring data integrity and regulatory acceptance across major global markets.

To eliminate internal bias:

• Quarterly random batch testing conducted by SGS and Eurofins
• Testing aligned with USP / EP pharmacopeial standards
• Double-blind validation protocols were applied where required

Because real quality is independently verified—not self-declared.